0 Commentaires
0 Parts
3KB Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Bio simulation Market to Surge to USD 16.69 Billion by 2032 Riding a 16.23% CAGR on Rising Biologics R&D, AI-Enabled Modelling and Demand for Cost-Efficient Drug DevelopmentBiosimulation Market remarkable growth is being driven by a confluence of factors: rapid expansion in biologics and biosimilar development, the escalating burden of chronic diseases, rising demand for precision medicine, and regulatory momentum favoring in-silico simulation to streamline drug development, reduce costs, and accelerate time-to-market. Quick Insights...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
Biologics Market Sales, Product Scope, Application, Future Prospects Forecast by 2032The latest research report by Emergen research named ‘Global Biologics market - Forecast to 2030’, entails a comprehensive review of the global Biologics market’s present and future trends. The report gathers viable information on the most established industry players, sales and distribution channels, regional spectrum, estimated market share and size, and revenue...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
Biologics Market Size Projected to Reach USD 1230.70 Billion by 2032“According to a new report published by Introspective Market Research, Biologics Market by Product Type, Application, and Manufacturing, The Global Biologics Market Size Was Valued at USD 509.3 Billion in 2023 and is Projected to Reach USD 1230.70 Billion by 2032, Growing at a CAGR of 10.3%.” Biologics, short for biological products, represent a transformative class of medicines...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Biologics Virus Filtration Market Overview: Key Drivers and ChallengesMarket Trends Shaping Executive Summary Biologics Virus Filtration Market Size and Share CAGR Value Global biologics virus filtration market size was valued at USD 2,316.72 million in 2024 and is projected to reach USD 5,082.85 million by 2032, with a CAGR of 10.32% during the forecast period of 2025 to 2032. Biologics Virus Filtration report has been formulated by keeping in...0 Commentaires 0 Parts 182 Vue 0 Aperçu
-
Market Intelligence Report on Biologics Contract Development Market : Size, Share, and Revenue 2032The Biologics Contract Development Market has emerged as a critical component of the global biopharmaceutical ecosystem, enabling drug developers to accelerate timelines, reduce operational risks, and access specialized technical expertise. As biologic therapies continue to dominate pharmaceutical innovation, the demand for outsourced contract development services is increasing steadily. The...0 Commentaires 0 Parts 319 Vue 0 Aperçu
-
Plant Cell Photobioreactors Market Report: High Demand for Sustainable Biologics Drives GrowthThe Global Plant Cell Photobioreactors Market Size Was Valued at USD 55.62 Billion in 2023 and is Projected to Reach USD 160.28 Billion by 2032, Growing at a CAGR of 10.1 % From 2024-2032. Plant Cell Photobioreactors (PBRs) are specialized cultivation systems designed to domesticate plant cells, tissues, or microalgae in a controlled, enclosed environment. Unlike traditional open pond systems...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Self-administered Biologics Market Growth is booming worldwide Analysis By FMINEWARK, DE | The self-administered biologics market was valued at USD 98.3 billion in 2025 and is estimated to reach USD 102.7 billion in 2026. Demand is projected to grow to USD 159.5 billion by 2036, reflecting a CAGR of 4.5% during the forecast period. This sustained expansion, with an absolute dollar growth of USD 56.8 billion over the decade, is anchored in the structural demand...0 Commentaires 0 Parts 241 Vue 0 Aperçu1
-
Wound Care Biologics Market Business Trends, Disruption Risks and Forecast to 2033Global Wound Care Biologics Market Snapshot: A new report titled “Global Wound Care Biologics Market” has been added to its vast repository by Straits Research. The report analyzes and estimates the market on a global, regional, and country level. The report offers data from previous years along with an in-depth analysis from 2025 to 2033 on the basis of revenue (USD Billion or...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Biologic Injectors Market Share Analysis by Geography – Global Industry Forecast to 2031The global Biologic Injectors market is set for robust expansion as biologic therapies continue revolutionizing treatment across major chronic diseases such as cancer, autoimmune disorders, and diabetes. Biologic injectors are specialized delivery systems designed for administering biologic drugs large, complex molecules like monoclonal antibodies and recombinant proteins safely and...0 Commentaires 0 Parts 331 Vue 0 Aperçu
-
Bioprocess Containers Market to Hit USD 4.18 Billion by 2032“According to a new report published by Introspective Market Research, the Bioprocess Containers Market by Product Type, Material, and End User, the Global Bioprocess Containers Market Size was Valued at USD 2.14 Billion in 2023 and is Projected to Reach USD 4.18 Billion by 2032, Growing at a CAGR of 12.2%.” The bioprocess containers market plays a vital role in modern...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Contract Manufacturing Boom Supporting API CDMO Market ExpansionRegulatory complexity in drug manufacturing is encouraging companies to rely on specialized CDMOs.Expert compliance management reduces operational risks and delays.This support is critical for global market expansion. Active Pharmaceutical Ingredients CDMO market The market is expected to grow steadily at a CAGR of 7.4% from 2025 to 2031, driven by innovation in drug development and the global...0 Commentaires 0 Parts 3KB Vue 0 Aperçu2
-
Global Romiplostim Market to Reach USD 2.75 Billion by 2034 Driven by Rising ITP CasesAccording to a new report from Intel Market Research, the global Romiplostim market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.75 billion by 2034, growing at a steady CAGR of 7.2% during the forecast period (2026-2034). This growth trajectory reflects the rising global burden of chronic immune thrombocytopenia (ITP) and increasing adoption of targeted biologic...0 Commentaires 0 Parts 689 Vue 0 Aperçu
-
Inflammatory Bowel Disease Treatment Market Reaching US$ 31.67B by 2031Inflammatory Bowel Disease Treatment focuses on managing chronic conditions such as Crohn’s disease and ulcerative colitis that cause persistent inflammation in the digestive tract. Treatment strategies aim to control inflammation, reduce symptom severity, prevent complications, and maintain remission. Therapeutic approaches include pharmacological interventions, biologics,...0 Commentaires 0 Parts 687 Vue 0 Aperçu
-
Market Outlook 2025–2031: Future of Sarcoma Drug DevelopmentOrphan drug designation is supporting market expansion.Regulatory incentives encourage rare cancer drug development.Faster approvals enhance product commercialization opportunities The Sarcoma Drugs Market is projected to witness steady growth, registering a CAGR of 7.9% from 2025 to 2031. The market size is expected to expand from US$ XX million in 2024 to US$ XX million by 2031, driven by...0 Commentaires 0 Parts 3KB Vue 0 Aperçu1
-
Recombinant Human Erythropoietin Injection Market to Reach USD 10.2 Billion by 2032 | CAGR 3.8%According to a newly published market research report by 24LifeSciences, the global recombinant human erythropoietin injection market was valued at USD 7.6 billion in 2024 and is projected to reach USD 10.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 3.8% during the forecast period 2025–2032. Recombinant human erythropoietin (rhEPO) injection is a...0 Commentaires 0 Parts 126 Vue 0 Aperçu
-
Sarcoma Drugs Market Forecast 2025–2031: Opportunities in Rare Cancer TherapiesThe rising demand for innovative cancer therapies is fueling the Sarcoma Drugs Market globally. Researchers are focusing on immunotherapy and combination therapies to improve treatment effectiveness. Such developments are strengthening the oncology drug pipeline. The Sarcoma Drugs Market is expected to register a CAGR of 7.9% from 2025 to 2031, with the market size expanding from US$ XX million...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
Plus de résultats